Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,378.40
(
0.56%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.38
(
-0.07%
)
Bitcoin
72,155.60
(
0.51%
)
News Focus
News Focus

Replies to post #148 on Chelsea Therapeutics Intl Ltd fka CHIP

Replies to #148 on Chelsea Therapeutics Intl Ltd fka CHIP
icon url

Drewett27

09/17/10 11:30 AM

#149 RE: surf1944 #148

Breaking out right now!
icon url

surf1944

09/20/10 8:48 AM

#150 RE: surf1944 #148

6:33AM Chelsea Therapeutics reports phase III trial of Northera met primary endpoint and achieved highly significant symptomatic benefits in Neurogenic Orthostatic Hypotension (CHTP) 5.06 :